Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lexaria Bioscience Corp.
Lexaria Receives USD$2.6 Million Tax Rebate Payment
September 1, 2026
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria’s 2026 Animal Study #2
August 24, 2026
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026
GLP-1 ‘Arms Race’ Intensifies as the Addressable Markets Continue to Expand
June 17, 2026
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
June 3, 2026
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
May 19, 2026
Lexaria Bioscience Releases Second Episode of Investor Video Series
May 7, 2026
Lexaria Updates Progress on Human Study #7
May 5, 2026
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
May 1, 2026
1
2
Next Page
→